Xconomy’s Digital Events →
December 3, 2020 · New York
Cambridge, MA-based Zafgen is developing a drug for severely obese people.
Sponsored · Whitepaper
How a patient-centric, technology-driven approach can broaden access to research and reach patients regardless of geography, ethnicity, sex, or gender
Sponsored · Webinar
How Functional Cell-based Assays Support Clinical Programs Managing Proinflammatory Cytokines Associated with High Mortality
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders
© 2007-2020, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.